Skip to main content

Advertisement

SpringerLink
Log in

Anticonvulsant drug or neuromodulator? The growing case for anticonvulsant uses beyond epilepsy

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Epilepsy drugs were often used for other disorders before their effectiveness in epilepsy was fully appreciated, and the efficacy of newer antiepileptic drugs for conditions other than epilepsy is now being studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Storey JR, Calder CS, Hart DE, Potter DL: Topiramate in migraine prevention: a double-blind, placebo-controlled trial. Headache 2001, 41:968–975. Well-designed trial supporting the effectiveness of topiramate in migraine.

    Article  PubMed  CAS  Google Scholar 

  2. Mathew NT, Rapoport A, Saper J, et al.: Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119–128.

    Article  PubMed  CAS  Google Scholar 

  3. Klapper J, on behalf of the Divalproex Sodium in Migraine Prophyllaxis Study Group: Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalgia 1997, 17:103–108.

    Article  CAS  Google Scholar 

  4. Spira PJ, Beran RG, for the Australian Gabapentin Chronic Headache Group: Gabapentin in the prophylaxis of chronic daily headache. Neurology 2003, 61:1753–1759. Well-designed trial supporting the effectiveness of gabapentin in chronic daily headache.

    PubMed  CAS  Google Scholar 

  5. Bowden CL, Calabrese JR, Sachs G, et al., for the Lamictal 606 Study Group: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003, 60:392–400. Well-designed trial supporting the effectiveness of lamotrigine in bipolar disorder.

    Article  PubMed  CAS  Google Scholar 

  6. Calabrese JR, Bowden CL, Sachs G, et al., for the Lamictal 605 Study Group: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003, 64:1013–1024.

    Article  PubMed  CAS  Google Scholar 

  7. Rowbotham M, Harden N, Stacey B, et al.: Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998, 280:1837–1842.

    Article  PubMed  CAS  Google Scholar 

  8. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al.: Treatment of restless legs syndrome with gabapentin: a double-blind, crossover study. Neurology 2002, 59:1573–1579.

    PubMed  CAS  Google Scholar 

  9. Dworkin RH, Corbin AE, Young JP, et al.: Pregabalin for the treatment of postherpetic neuralgia. Neurology 2003, 60:1274–1283.

    PubMed  CAS  Google Scholar 

  10. Pande AC, Crockatt JG, Feltner DE, et al.: Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 2003, 160:1–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurological Institute of New York, Columbia University College of Physicians & Surgeons, 710 West 168th Street, 10032, New York, NY, USA

    Carl W. Bazil MD, PhD

Authors
  1. Carl W. Bazil MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bazil, C.W. Anticonvulsant drug or neuromodulator? The growing case for anticonvulsant uses beyond epilepsy. Curr Neurol Neurosci Rep 4, 305–307 (2004). https://doi.org/10.1007/s11910-004-0056-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-004-0056-y

Keywords

Search

Navigation